Cargando…

Vaccine uptake and barriers to vaccination among at-risk adult populations in the US

To reduce morbidity and mortality associated with vaccine-preventable diseases (VPD), it is imperative that vaccination programs are implemented and prioritized throughout all stages of life across all populations. This study aimed to determine vaccine uptake and barriers to vaccination against VPDs...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolobova, Irina, Nyaku, Mawuli Kwame, Karakusevic, Anna, Bridge, Daisy, Fotheringham, Iain, O’Brien, Megan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248946/
https://www.ncbi.nlm.nih.gov/pubmed/35536017
http://dx.doi.org/10.1080/21645515.2022.2055422
_version_ 1784739463331577856
author Kolobova, Irina
Nyaku, Mawuli Kwame
Karakusevic, Anna
Bridge, Daisy
Fotheringham, Iain
O’Brien, Megan
author_facet Kolobova, Irina
Nyaku, Mawuli Kwame
Karakusevic, Anna
Bridge, Daisy
Fotheringham, Iain
O’Brien, Megan
author_sort Kolobova, Irina
collection PubMed
description To reduce morbidity and mortality associated with vaccine-preventable diseases (VPD), it is imperative that vaccination programs are implemented and prioritized throughout all stages of life across all populations. This study aimed to determine vaccine uptake and barriers to vaccination against VPDs among at-risk adult populations in the United States. We conducted a systematic literature review for articles published between January 2010 and June 2020 and identified 153 publications. The review identified 17 at-risk populations. Vaccine uptake was suboptimal among many populations, with factors including age, gender, and disease severity, associated with uptake. This review identified several barriers that impact vaccine uptake among at-risk populations, with concerns over safety, vaccine costs, lack of insurance, and lack of provider recommendation commonly reported across populations. Embracing a national life-course immunization framework that integrates developing policies, guidelines, and education would be a step to addressing these barriers.
format Online
Article
Text
id pubmed-9248946
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-92489462022-07-02 Vaccine uptake and barriers to vaccination among at-risk adult populations in the US Kolobova, Irina Nyaku, Mawuli Kwame Karakusevic, Anna Bridge, Daisy Fotheringham, Iain O’Brien, Megan Hum Vaccin Immunother Acceptance – Review To reduce morbidity and mortality associated with vaccine-preventable diseases (VPD), it is imperative that vaccination programs are implemented and prioritized throughout all stages of life across all populations. This study aimed to determine vaccine uptake and barriers to vaccination against VPDs among at-risk adult populations in the United States. We conducted a systematic literature review for articles published between January 2010 and June 2020 and identified 153 publications. The review identified 17 at-risk populations. Vaccine uptake was suboptimal among many populations, with factors including age, gender, and disease severity, associated with uptake. This review identified several barriers that impact vaccine uptake among at-risk populations, with concerns over safety, vaccine costs, lack of insurance, and lack of provider recommendation commonly reported across populations. Embracing a national life-course immunization framework that integrates developing policies, guidelines, and education would be a step to addressing these barriers. Taylor & Francis 2022-05-10 /pmc/articles/PMC9248946/ /pubmed/35536017 http://dx.doi.org/10.1080/21645515.2022.2055422 Text en © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Acceptance – Review
Kolobova, Irina
Nyaku, Mawuli Kwame
Karakusevic, Anna
Bridge, Daisy
Fotheringham, Iain
O’Brien, Megan
Vaccine uptake and barriers to vaccination among at-risk adult populations in the US
title Vaccine uptake and barriers to vaccination among at-risk adult populations in the US
title_full Vaccine uptake and barriers to vaccination among at-risk adult populations in the US
title_fullStr Vaccine uptake and barriers to vaccination among at-risk adult populations in the US
title_full_unstemmed Vaccine uptake and barriers to vaccination among at-risk adult populations in the US
title_short Vaccine uptake and barriers to vaccination among at-risk adult populations in the US
title_sort vaccine uptake and barriers to vaccination among at-risk adult populations in the us
topic Acceptance – Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248946/
https://www.ncbi.nlm.nih.gov/pubmed/35536017
http://dx.doi.org/10.1080/21645515.2022.2055422
work_keys_str_mv AT kolobovairina vaccineuptakeandbarrierstovaccinationamongatriskadultpopulationsintheus
AT nyakumawulikwame vaccineuptakeandbarrierstovaccinationamongatriskadultpopulationsintheus
AT karakusevicanna vaccineuptakeandbarrierstovaccinationamongatriskadultpopulationsintheus
AT bridgedaisy vaccineuptakeandbarrierstovaccinationamongatriskadultpopulationsintheus
AT fotheringhamiain vaccineuptakeandbarrierstovaccinationamongatriskadultpopulationsintheus
AT obrienmegan vaccineuptakeandbarrierstovaccinationamongatriskadultpopulationsintheus